四君子汤联合奥美拉唑对体外循环胃肠道保护作用的实验研究
|
摘要
第一部分无血预充兔体外循环模型的建立
目的探索建立无血预充兔体外循环模型的方法,为进一步的实验研究打下基础。
方法3O只新西兰兔,采用右心房引流,右锁骨下动脉灌注的方法,建立兔体外循环模型,并监测转流前、中、后动脉血气的变化。
结果成功建立起无血预充兔体外循环模型,动脉血气各项指标结果满意。
结论证明建立无血预充兔体外循环模型是可行的。
第二部分四君子汤和奥美拉唑对兔体外循环模型胃肠道保护作用的研究
目的研究四君子汤和奥美拉唑对兔体外循环模型胃肠道的保护作用,为临床应用打下基础。
方法建立兔体外循环模型,给予不同的治疗方法后,在体外循环不同时间点检测胃pHi、血浆内毒素(LPS)、二胺氧化酶(DAO)、肿瘤坏死因子-α(TNF-α)的水平变化,并行实验动物胃组织切片检查,以确定体外循环对胃肠道功能的影响以及不同药物运用对胃肠道的保护作用。
结果各组检测指标体外循环后各时间点与体外循环前都有明显差异;各治疗组的胃pHi均高于对照组,而四君子汤和奥美拉唑联合用药治疗组的胃pHi又高于单独用药治疗组;各治疗组的LPS、DAO、TNF-α水平均低于对照组,而四君子汤和奥美拉唑联合用药治疗组的各指标水平又低于单独用药治疗组;实验动物组织切片检查显示联合治疗组的胃粘膜损伤明显轻于对照组。
结论体外循环对胃肠功能有明显的影响,四君子汤与奥美拉唑单独运用对体外循环时的胃肠道功能均有保护作用,四君子汤与奥美拉唑联合用药的保护作用更加明显,具有良好的临床应用前景。
第三部分四君子汤联合奥美拉唑对体外循环胃肠道保护作用的临床研究
目的研究四君子汤联合奥美拉唑对心脏手术体外循环中胃肠道的保护作用。
方法60例体外循环下心内直视手术成人患者,随机分为4组:治疗1组(B组)在CPB预充液中加入奥美拉唑40mg,术后12h后再静脉给予奥美拉唑40mg;治疗2组(C组)手术前一天分两次给予四君子汤(含生药1g/ml)200ml,术后12小时通过胃管再给予100ml;治疗3组(D组)按上述方法联合用药;对照组给予等量生理盐水。在体外循环不同时间点检测胃pHi、血浆内毒素(LPS)、二胺氧化酶(DAO)、肿瘤坏死因子-α(TNF-α)的水平变化,并进行术后临床症状的观察,以确定不同药物运用对胃肠道的保护作用。
结果各治疗组的胃pHi均高于对照组,而四君子汤和奥美拉唑联合用药治疗组的胃pHi又高于单独用药治疗组;各治疗组的LPS、DAO、TNF-α水平均低于对照组,而四君子汤和奥美拉唑联合用药治疗组的各指标水平又低于单独用药治疗组;各治疗组出现临床症状患者明显少于对照组;
结论在心脏手术体外循环中四君子汤与奥美拉唑联合用药可明显减轻体外循环对胃肠道的损伤作用,具有良好的应用前景。
PartⅠEstablishment of a Rabbit Model of Cardiopulmonary Bypass Flushed without Blood
Objective To establish a rabbit model of the cardiopulmonary bypass (CPB) flushed without blood.
Method Thirty New Zealand rabbits were included in this experiment. The CPB procedure was established via right subclavian artery and right atrium cannulation. The blood-gas parameters were examined before and after CPB.
Results The rabbit cardiopulmonary bypass model was established successfully. The results of arterial blood gas analysis were satisfactory. No hemorrhage and operation death occurred in this experiment.
Conclusion A rabbit model of cardiopulmonary bypass flushed without blood has been established and showed to be feasible for related pathophysiological research work.
PartⅡExperimental Study on the Protection of Sijunzi Decoction and Omeprazole for the Gastroenteric Function of the Rabbit Cardiopulmonary Bypass Models
Objective To investigate the protection of sijunzi decoction and omeprazole for the gastroenteric function of the rabbit cardiopulmonary bypass models.
Methods Rabbit cardiopulmonary bypass models flushed without blood were established and treated with sijunzi decoction and omeprazole. The levels of pHi, LPS, DAO, TNF-αwere detected in different time of cardiopulmonary bypass and tissue sections were observed to research the influence of cardiopulmonary bypass on the gastroenteric function and the protection of different treatments.
Results The indicators after cardiopulmonary bypass showed conspicuous difference from the preoperative’s. The pHi levels of all treated groups were higher than control group and the levels of LPS, DAO and TNF-αwere lower than control group. The tissue sections showed more damagement of gastrointestinal mucosa in control group.
Conclusion Cardiopulmonary bypass did damage to gastroenteric function. The medication of sijunzi decoction and omeprazole respectively showed protection for the gastroenteric function in cardiopulmonary bypass and the medication of sijunzi decoction with omeprazole together showed more significant protection.
PartⅢClinical Research on the Gastroenteric Protection of the Medication of Sijunzi Decoction with Omeprazole together in Cardiopulmonary Bypass
Objective To investigate the the gastroenteric protection of the medication of sijunzi decoction with omeprazole together in cardiopulmonary bypass.
Methods Sixty adult patients were randomized equally into 4 groups. The levels of pHi, LPS, DAO, TNF-αwere detected in different time of cardiopulmonary bypass and clinical symptoms were observed to research the gastroenteric protection of different treatments.
Results The pHi levels of all treated groups were higher than control group and the levels of LPS, DAO and TNF-αwere lower than control group. The clinical symptoms were more frequent in control group.
Conclusion The medication of sijunzi decoction with omeprazole together showed significant gastroenteric protection in cardiopulmonary bypass.
目的探索建立无血预充兔体外循环模型的方法,为进一步的实验研究打下基础。
方法3O只新西兰兔,采用右心房引流,右锁骨下动脉灌注的方法,建立兔体外循环模型,并监测转流前、中、后动脉血气的变化。
结果成功建立起无血预充兔体外循环模型,动脉血气各项指标结果满意。
结论证明建立无血预充兔体外循环模型是可行的。
第二部分四君子汤和奥美拉唑对兔体外循环模型胃肠道保护作用的研究
目的研究四君子汤和奥美拉唑对兔体外循环模型胃肠道的保护作用,为临床应用打下基础。
方法建立兔体外循环模型,给予不同的治疗方法后,在体外循环不同时间点检测胃pHi、血浆内毒素(LPS)、二胺氧化酶(DAO)、肿瘤坏死因子-α(TNF-α)的水平变化,并行实验动物胃组织切片检查,以确定体外循环对胃肠道功能的影响以及不同药物运用对胃肠道的保护作用。
结果各组检测指标体外循环后各时间点与体外循环前都有明显差异;各治疗组的胃pHi均高于对照组,而四君子汤和奥美拉唑联合用药治疗组的胃pHi又高于单独用药治疗组;各治疗组的LPS、DAO、TNF-α水平均低于对照组,而四君子汤和奥美拉唑联合用药治疗组的各指标水平又低于单独用药治疗组;实验动物组织切片检查显示联合治疗组的胃粘膜损伤明显轻于对照组。
结论体外循环对胃肠功能有明显的影响,四君子汤与奥美拉唑单独运用对体外循环时的胃肠道功能均有保护作用,四君子汤与奥美拉唑联合用药的保护作用更加明显,具有良好的临床应用前景。
第三部分四君子汤联合奥美拉唑对体外循环胃肠道保护作用的临床研究
目的研究四君子汤联合奥美拉唑对心脏手术体外循环中胃肠道的保护作用。
方法60例体外循环下心内直视手术成人患者,随机分为4组:治疗1组(B组)在CPB预充液中加入奥美拉唑40mg,术后12h后再静脉给予奥美拉唑40mg;治疗2组(C组)手术前一天分两次给予四君子汤(含生药1g/ml)200ml,术后12小时通过胃管再给予100ml;治疗3组(D组)按上述方法联合用药;对照组给予等量生理盐水。在体外循环不同时间点检测胃pHi、血浆内毒素(LPS)、二胺氧化酶(DAO)、肿瘤坏死因子-α(TNF-α)的水平变化,并进行术后临床症状的观察,以确定不同药物运用对胃肠道的保护作用。
结果各治疗组的胃pHi均高于对照组,而四君子汤和奥美拉唑联合用药治疗组的胃pHi又高于单独用药治疗组;各治疗组的LPS、DAO、TNF-α水平均低于对照组,而四君子汤和奥美拉唑联合用药治疗组的各指标水平又低于单独用药治疗组;各治疗组出现临床症状患者明显少于对照组;
结论在心脏手术体外循环中四君子汤与奥美拉唑联合用药可明显减轻体外循环对胃肠道的损伤作用,具有良好的应用前景。
PartⅠEstablishment of a Rabbit Model of Cardiopulmonary Bypass Flushed without Blood
Objective To establish a rabbit model of the cardiopulmonary bypass (CPB) flushed without blood.
Method Thirty New Zealand rabbits were included in this experiment. The CPB procedure was established via right subclavian artery and right atrium cannulation. The blood-gas parameters were examined before and after CPB.
Results The rabbit cardiopulmonary bypass model was established successfully. The results of arterial blood gas analysis were satisfactory. No hemorrhage and operation death occurred in this experiment.
Conclusion A rabbit model of cardiopulmonary bypass flushed without blood has been established and showed to be feasible for related pathophysiological research work.
PartⅡExperimental Study on the Protection of Sijunzi Decoction and Omeprazole for the Gastroenteric Function of the Rabbit Cardiopulmonary Bypass Models
Objective To investigate the protection of sijunzi decoction and omeprazole for the gastroenteric function of the rabbit cardiopulmonary bypass models.
Methods Rabbit cardiopulmonary bypass models flushed without blood were established and treated with sijunzi decoction and omeprazole. The levels of pHi, LPS, DAO, TNF-αwere detected in different time of cardiopulmonary bypass and tissue sections were observed to research the influence of cardiopulmonary bypass on the gastroenteric function and the protection of different treatments.
Results The indicators after cardiopulmonary bypass showed conspicuous difference from the preoperative’s. The pHi levels of all treated groups were higher than control group and the levels of LPS, DAO and TNF-αwere lower than control group. The tissue sections showed more damagement of gastrointestinal mucosa in control group.
Conclusion Cardiopulmonary bypass did damage to gastroenteric function. The medication of sijunzi decoction and omeprazole respectively showed protection for the gastroenteric function in cardiopulmonary bypass and the medication of sijunzi decoction with omeprazole together showed more significant protection.
PartⅢClinical Research on the Gastroenteric Protection of the Medication of Sijunzi Decoction with Omeprazole together in Cardiopulmonary Bypass
Objective To investigate the the gastroenteric protection of the medication of sijunzi decoction with omeprazole together in cardiopulmonary bypass.
Methods Sixty adult patients were randomized equally into 4 groups. The levels of pHi, LPS, DAO, TNF-αwere detected in different time of cardiopulmonary bypass and clinical symptoms were observed to research the gastroenteric protection of different treatments.
Results The pHi levels of all treated groups were higher than control group and the levels of LPS, DAO and TNF-αwere lower than control group. The clinical symptoms were more frequent in control group.
Conclusion The medication of sijunzi decoction with omeprazole together showed significant gastroenteric protection in cardiopulmonary bypass.
引文
1. Plestis KA, Gold JP. Importance of blood pressure regulation in maintaining adequate tissue perfusion during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg. 2001,13(2):170-175.
2. Fung M, Loubser PG, Undar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg. 2001,122(1):113-122.
3. Meloni L, Abbruzzese PA, Cardu G, Aru GM, et al. Detection of microbubbles released by oxygenators during cardiopulmonary bypass by intraoperative transesophageal echocardiography. Am J Cardiol. 1990,15;66(4):511-4. No abstract available.
4. St-Pierre J, Fortier LP, Couture P, Hebert Y. Massive gastrointestinal hemorrhage after transoesophageal echocardiography probe insertion. Can J Anaesth. 1998,45(12): 1196- 1199.
5. Perugini RA, Orr RK, Porter D, Dumas EM, et al. Gastrointestinal complications following cardiac surgery. An analysis of 1477 cardiac surgery patients. Arch Surg. 1997,132(4):352-357.
6. Sinclair DG, Houldsworth PE, Keogh B, Pepper J, et al. Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intensive Care Med. 1997,23(5):510-516.
7. Klemperer JD, Ko W, Krieger KH, Connolly M, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg. 1998,65(1):85-87.
8. Mollhoff T, Loick HM, Van Aken H, et al. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Anesthesiology. 1999,90(1):72-80.
9. Hyde JA, Riddington DW, Hutton P, et al. Prevention of remote organ injury in cardiopulmonary bypass: the impact of flow generation technique. Artif Organs. 1997,21(7):825-829.
10. St-Pierre J, Fortier LP, Couture P, et al. Massive gastrointestinal hemorrhage after transoesophageal echocardiography probe insertion. Can J Anaesth. 1998 ,45(12):1196-1199.
11. McNicol L, Andersen LW, Liu G, et al. Markers of splanchnic perfusion and intestinal translocation of endotoxins during cardiopulmonary bypass: effects of dopamine and milrinone. J Cardiothorac Vasc Anesth. 1999,13(3):292-298.
12. Ogino H, Miki S, Ueda Y, Tahata T. A case of bowel necrosis due to acute mesenteric ischemia following pulsatile cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 1998 ,4(1):34-36.
13.郑利民刘小玲夏中元.体外循环心脏手术中复方丹参注射液对胃肠道保护作用的临床观察.中国中西医结合杂志,2001,21(3):177-179.
14.詹丽英,夏中元,夏芳,等.参附注射液对体外循环期间胃肠灌注及氧合的影响.中国现代医学杂志,2005,15(18):2814-2816.
1. Williams EA, W elty SE,G eske RS,et a1.Liquid lung ventilation reduces neutrophil sequestration in a neonatal swine model of cardiopulmonary bypass. Crit Care Med,2001,29(4):789-795.
2. Baldwin RT, Kadipasaoglu KA,Radovancevic B,et a1. The development of aclinically relevant canine model of postperfusion syndrome. ASAIO Trans,1991,37(3):M484-485.
3. Grehan JF,Casagrande I,Oliveira EL,et a1. A juvenile sheep model for the long-term evaluation of stentless bioprostheses implanted as aortic root replacements.J Heart Valve Dis,2001,10(4):505-512.
4. Kim WG, Moon HJ, Won TH, et al. Rabbit model of cardiopulmonary bypass. Perfusion,1999,14(2):101-105.
5.张石江,高声甫,高采璋.微型体外循环和兔体外循环.中华实验外科杂志,1991,8(1):46-47.
6.于洋,叶明,夏求明.兔体外循环模型的建立.中国胸心血管外科杂志,2003,10(2):151-152.
7.徐鹏,易定华.兔体外循环对胃泌素及其受体的影晌.第四军医大学学报,2000,21(4):302-304.
8.张斌杰,张永奎,乐涵波,等.兔体外循环氧合器改装和使用的实验研究医疗装备,2002,15(1):32-34.
9. Rogers AT. A rabbit model of the brain and cardiopulmonary bypass. Anesthesiology,1998,88(6):565-566.
10. Kuratani T, Matsuda H, Sawa Y, et al. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1992,103(6):564-568.
11. Xu X, Zhou Y, Ma Q, et al. Establishing a resuscitation model in rabbits withclosed-thoracic cardiopulmonary bypass.Resuscitation,1994,27(1):61-66.
1 Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg,1993,55(55):l080-1086.
2 Martin LF,Booth FV,Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med,1993,21(1):19-30.
3 Ohri SK,Becket J,Brannan J,et a1.Effects of cardiopulmonary bypass on gut blood flow,oxygen utilization,and intramucosal pH.Ann Thorac Surg,1994,57(5):1193-1199.
4胡小琴.血管手术时炎症反应.中华麻醉学杂志.2001,21(10):592-595.
5. Thoren A,Jakob SM,Pradl R,et a1.Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism:an observational study on postcardiac surgical patients.Crit Care Med,2CO0,28(11):3649-3654.
6. Bichel T,Kalangos A,Rouge JC. Can gastric intramucosal pH (pHi)predict outcome of paediatric cardiac surgery?.Paediatr Anaesth,1999,9(2):129-134.
7黎君友,吕艺,付小兵,等.二胺氧化酶在创伤后肠道损伤中变化及意义.中国危重病急救医学,2000,12(8):482-484.
8乐桥良,张捷,许其增,等.一氧化氮在奥美拉唑对大鼠胃粘膜保护中的作用[J].第一军医大学学报,2001,21(12):926—928.
9.陆国明,李玉梅,郭连军,等.应激状态下NO的胃粘膜保护作用及其与壁细胞泌酸的关系[J].中国应用生理学杂志,2005,21(3):301—304.
10.Arroyo MT,Lanas A,Sainz R.Prevention and healing of experimental indomethacin- induced gastric lesions:effects of ebrotidine,omeprazole and ranitidine.Eur J Gastroenterol Hepatol, 2000,12(3):313-318.
11董小超,易定华,刘金成,等.体外循环心脏手术中奥美拉唑对胃肠道保护作用的临床观察.中国急救医学,2006,26(5):331-333.
12 Olcb L.Effect of omeprazole on gastric acid secretion a plasma gastrin man[J].Scand J Gastroenterol,1989,24(Suppl 166):27—32.
13. Ogino H, Miki S, Ueda Y,et a1. A case of bowel necrosis due to acute mesenteric ischemia following pulsatile cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 1998,4(1):34-36.
14.彭成,雷载权.四君子汤对消化、运动、吸收作用的实验研究.中药药理与临床,1995,11(5):6-8.
15易崇勤,孙建宁,张家俊,等.四君子汤调整小鼠运化功能紊乱的实验研究.中国中西医结合杂志,1997,17(1):42-44.
16张曼,陈蔚文,叶富强.等.四君子汤A、B成分双向调节大鼠胃运动的M受体作用机制.河南中医药学刊,2002,17(4):9-11.
17任平,黄熙,谢良杰.四君子汤对脾虚模型大鼠胃动素和前列腺素E2含量的影响.中药药理与临床,1994,10(6):7-8.
18任平,黄熙,张莉,等.四君子汤对实验性脾虚大鼠胃捧空率的影响.中国中西医结合杂志,2000,20(8):596-598.
19魏彦明,宗瑞谦,杨孝朴,等.实验性脾虚证大鼠血浆胃泌素和胃动素含量化及四君子汤对其调整作用.中国兽医学报,2001,21(3):281-283.
20.宋开源,刘旭光,汪开明,等.辰、戌时辰四君子汤治疗对“脾虚证”大鼠血清胃泌素昼液节律性的影响.成都中医药大学学报,1996,19(1):32-35.
21易崇勤,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响.北京中医药大学学报,1997,20(6):31-34.
22彭成,雷载权.四君子汤抗脾虚动物胃肠细胞实验损伤的机理研究.中药药理与临床,1996,12(1):1-4.
23刘良,周华,王培训,等.四君子汤复方总多糖对小鼠肠道黏膜相关淋巴组织的影响.中国免疫学杂志,2000,17(4):204-207.
1. Tsiotos GG,Mulany CJ,Zietlow S,et a1. Abdominal complications following cardiac surgery. Am J Surg,1994,167:553—557.
2. Mercado PD,Farid H,O Connell TX,et a1.Gastrointestinal complications associated with cardiopulmonary bypass procedures. Am J Surg,1994,60:789—792.
3. Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut p ermeability. Ann Thorac Surg,1993,55:l080-1086.
4. Martin LF,Booth MV,Kar]stadt RG.et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med,1993,21:19—30.
5. Sunil K,Jenny B,John B,et a1.Effects of cardiopulmonary bypass on gut blood flow,oxygen utilization,and intramucosal pH[J].Ann Throae Surg,1994,57:1193-1199.
6. Thoren A,Jakob SM,Pradl R,et a1.Jejunal and gastric mucosal perfusion versus splanehnie blood flow and metabolism:an observational study on postcardiac surgical patients[J].Crit Care Med,2CO0,28:3649-3654.
7. Biehel T,Kalangos A,Rouge JC. Can gastric intramucosal pH predict outcome of paediatric cardiac surgery?[j].Paediatr Anaesth,1999,9:129.
8. Arroyo MT,Lanas A,Sainz R,et a1.Prevention and healing of experimental indomethac in induced gastric lesions : effects of ebrotidine , omeprazole and ranitidine[J].Eur J Gastroenterol Hepatol, 2000,12(3):313—318.
9. Arroyo MT,Lanas A,Sainz R,et a1.Prevention and healing of expefimental indomethac in induced gastric lesions:effects of ebrotidine,omeprazole and ranitidine. Eur J Gastroenteml Hepatol,2000,12(3):313-318.
10. Anna-Leena K,Ruuska T,Karikoski,et a1.A randomized controlled study of prophylactic ranitidine in preventing stress-induced gastricmucosal lesions in neonatal intensive coi'e unit patients. Cfit Care Med,1997,25(2):346-351.
11. Tenenbaum J.The epidemiology of nonsteroidal anti- inflammatory drugs. Can J Gastroenteml,1999,13(2):l19-122.
12.许得盛,沈自尹,王文健,等.右归饮、四君子汤、桃红四物汤调节肾虚、脾虚、血瘀证患者免疫功能的观察.中国中西医结合杂志,1999,19:712-714.
1. Oudemans-van Straaten HM, Jansen PG, Hoek FJ, et al. Intestinal permeability, circulating, endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 1996; 10(2):187-194.
2. Sinclair DG, Haslam PL, Quinlan GJ, et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest, 1995, 108,718-724
3. Perugini RA, Orr RK, Porter D, et al. Gastrointestinal complications following cardiac surgery. An analysis of 1477 cardiac surgery patients. Arch Surg, 1997, 132(4):352-357.
4. Plestis KA, Gold JP. Importance of blood pressure regulation in maintaining adequate tissue perfusion during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg, 2001, 13(2):170-175.
5. Holmes JH, Lieberman JM, Probert CB, et a1. Elevated intestinal fatty acid binding protein and gastrointestinal complication following cardiopulmonary bypass: a preliminary analysis. J Surg Res, 2001, 100(9): 192-196.
6. Ohri SK, Bowels CW, Mathle RT, et a1. Efect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow . Ann Thorac Surg,1997, 64(10): 163-169.
7. Thoren A, Jakob SM, Pradl R, et a1. Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism: an observational study on postcardiac surgical patients. Crit Care Med, 2000, 28(5):3649-3654.
8. Slater JM, Orszulak TA, Cook DJ. Distribution and hierarchy of regional blood flowduring hypothermic cardiopulmonary bypass. Ann Thorac Surg, 2001, 72(2): 542-54.
9. Fung M, Loubser PG, Undar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg., 2001, 122(1):113-22.
10. Meloni L, Abbruzzese PA, Cardu G, Aru GM, et al. Detection of microbubbles released by oxygenators during cardiopulmonary bypass by intraoperative transesophageal echocardiography. Am J Cardiol, 1990, 66(4): 511-514.
11. Blauth CI, Arnold JV, Schulenberg WE, et al. Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. J Thorac Cardiovasc Surg. 1988, 95(4):668-76.
12. El Eter E, Hagar HH, AI-Tuwaijiri A, et a1. Nuclear factor-kappaB inhibition by pyrrolidinedithio carbamate attenuates gastric ischemia-reperfusion injury in rats. Can J Physiol Pharmacol, 2005, 83 (6): 483-492.
13. Kim H, Hwan Kim K. Role of nitric oxide and mucus in ischemia-reperfusion induced gastric mucosal injury in rats. Pharmacology, 2001, 62(4):200-207.
14. Wada K, Kamisaki Y, Ohkura T, et a1. Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats. Am J Physiol, 1998, 274(3 Pt 1):G465-471.
15. Derin N, zgut-Uysal VN, Agac A, et a1. L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. Physiol Pharmacol, 2004, 5(3):595-606.
16.叶方,徐鑫荣.创伤性休克大鼠心肺血栓调节蛋白表达的变化和意义.安徽医药,2005,9(8):606-608.
17. Wada K, Kamisaki Y, Kitano M et a1. A new gastric ulcer model induced by schemia-reperfusion in the rat; role of leukoeytes on ulceration in rat stomach. Life Sci, 1996, 59(19):295-301.
18. Brzozowski T, Konturek PC, Konturek SJ, et a1. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol, 2005, 56(Suppl5): 33-55.
19. Kotani T, Kobata A , Nakamura E , et a1 . Roles of cyclooxygenase-2 and Prostacyclin/IP receptors in mucosal defense against Isehemia/Reperfusion injury in mouse stomach.J Pharmacol Exp Ther,2006,316(2):547-555
20. Villegas I,Martin AR,Toma W,et a1.Rosiglitazone,an agonist of peroxisome proliferators-activated receptor gamma,protects against gastric ischemia-reperfusion damage in rats:role of oxygen free radicals generation.Eur J Pharmacol,2004,505(1-3):195-203.
21. Wada K,Nakajima A,Takahashi H,et a1.Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion.Am J Physiol Gastrointest Liver[J].Physiol,2004,287(2):G452-458.
22. Muia C, Mazzon E, Crisafulli C. Role of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice. Shock, 2006, 25(1):17-22.
23. Byhahn C, Strouhal U, Martens S, et al. Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg, 2001, 25(9):1140-1144.
24.徐鹏,易定华.兔体外循环对胃泌素及其受体的影响.第四军医大学学报,2000,21(4):502-504.
25.黑飞龙,龙村,孙桂民,等.体外循环心内直视手术中胃肠激素变化.中华实验外科杂志,2003,20(4):375.
26. Withington DE,Man WK,Elliott MJ . Histamine release during paediatric cardiopulmonary bypass. Can J Anaesth. 1993, 40(4):334-339.
27. Giuseppe D, Ancona, MD,Richard Baillot, MD,Brigitte Poirier, MD,et al. Determinants of Gastrointestinal Complications in Cardiac Surgery. Tex Heart Inst J 2003; 30(4):280-285.
28. Tsiotos GG, Mullany CJ, Zietlow S, et al. Abdominal complications following cardiac surgery. Am J Surg, 1994; 167(6):553-557.
29. Huddy SP, Joyce WP, Pepper JR. Gastrointestinal complications in 4473 patients who underwent cardiopulmonary bypass surgery. Br J Surg, 1991, 78(3):293-296.
30. Zacharias A, Schwann TA, Parenteau GL, et a1.Predictors of gastrointestinal complicationsin cardiac surgery. Tex Heart Inst J, 2000, 27(2):93-99.
31. Edmunds L H Jr. Complications of cardiac surgery. Cardiac Surgery in the Adult. New York: Mcgraw-Hil, 1997, 389-392.
32. Mierdl S,Meininger D,Dogan S.Abdominal complications after cardiac surgery.Ann Acad Med Singapore,2001,30(3):245-249.
33. Christenson JT, Schmuziger M, Maurice J. et al. Postoperative visceral hypotension the common cause for gastrointestinal complications after cardiac surgery. Thorac Cardiovas Surg, 1994, 42(3):152-157.
34.郭惠明,张镜芳,吴若彬,等.心脏手术后腹部并发症.中山大学学报(医学科学版),2004,25(3S):271-273.
35. Huwer H,Winning J,Stranb U,et al.Clinically diagnosed nonocclusive mesenteric ischemia after cardiopulmonary bypass:retrospective study. Vascular, 2004, 12(2):114-120.
36. 36 Akpinar B, Sagbae E,Gudeo M.Acute gastrointestinal complications after open heart surgery.Asian CardiovascThorac Ann,2000,8:109-113..
37. Garofalo M,Borioni R,Nardi P,et a1.Early diagnosis of acute mesenteric ischemia after cardiopulmonary bypass.J Cardiovasc Surg(Torino),2002, 43(4):455-459.
38. Wan S,Arifi AA,Chan CS.Is hyperamylasemia after cardiac surgery due to cardiopulmonary bypass? Asian Cardiovasc Thorac Ann,2002,10(2):115-118.
39.董国华,景华,李德闽,等.体外循环术后消化系统功能障碍的临床分析.中国医师杂志,2004,(6)11:1498-1500.
40. Ghosh S,Roberts N,Firmin RK,et a1.Risk factors for intestinal ischaemia cardiac surgical patients.Eur J Cardiothorac Surg, 2002,21(3):411-416.
41. Spotnitz WD, Sanders RP, Hanks JB, et al. General surgical complications can be predicted after cardiopulmonary bypass. Ann Surg, 1995; 221:489-97.
42.史昕云,夏正远,万建国,等.复方丹参注射液对心内直视手术心肌缺血再灌注后血清内皮素及前列环素/血栓素A2比值的影响.中国中西医结合杂志,2000,20(12):896-898.
43.常青,李和泉,原泽茂.丹参对大鼠胃泌素所致胃液分泌、胃体、十二指肠粘膜血流和胃窦运动的影响.中国病理生理杂志,1994,10(3):306-309.
44.常江,邓长生,沈佩弟,等.丹参对大鼠乙醇性胃粘膜损伤的保护作用的研究.中国病理生理杂志,994;10(1):27-29.
45.郑利民刘小玲夏中元.体外循环心脏手术中复方丹参注射液对胃肠道保护作用的临床观察.中国中西医结合杂志,2001,21(3):177-179.
46.田宝文,张强华,周钢,等.丹参和654—2对体外循环胃肠缺血再灌注损伤的保护作用.中国体外循环杂志,2004,2(3):142-144.
47.田宝文,张强华,周钢.丹参注射液对体外循环心脏手术后胃肠功能的影响.心血管康复医学杂志,2004,13(4):396-397.
48.顾家珍,夏正远,杨光,等.复方丹参对体外循环下心肌缺血再灌注后脂质过氧化反应的影响.中华实验外科杂志,1996:13(5):282-283.
49.吴志,夏正远,黄海波,等.复方丹参对心内直视手术心肌缺血再灌注后血清过氧化脂质及前列环素变化的影响.临床麻醉学杂志,2002,18(5):242-244.
50.阎勇,田伏洲,尹致志,等.丹参对肠道屏障的保护作用机制研究.中华消化杂志.2000,20(6):4O9-411.
51.龙村,邓硕曾.体外循环对消化系统的影响.国外医学麻醉学与复苏分册.1998;19(3):170-172
52.刘先义,邹捍东,余金甫,等.参附注射液对缺血再灌注家兔多脏器损伤的治疗作用.中华麻醉学杂志,1997,17(7):430-432.
53.詹丽英,夏中元,夏芳,等.参附注射液对体外循环期间胃肠灌注及氧合的影响.中国现代医学杂志,2005,15(18):2814-2816.
54. XIA Zhong-yuan,ZHAN Li-ying, XIA Fang,et al.The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardiopulmonary bypass in patients undergoing cardiac surgery. Chin J Traumatol(English Edition),2003,6 (4):245-248.
55.王正荣,杨芳炬,徐彬,等.参附注射液对肠系膜微循环的作用.中药药理与临床,2000;17(4):8-9.
56.蓝庆荣,吴树勋,李兰芳,等.参附注射液对失血性休克家免血乳酸和PCA的影响.中成药研究,1993,5(4):13.
57.夏中元,王龙,陈雪君,等.参附注射液对休克复苏时肠黏膜保护作用机制的实验研究.中国急救医学,2001, 21 (8):447-448.
58.夏中元,郑利民.参附注射液防护肠黏膜缺血再灌注损伤的实验研究.中国创伤杂志,2001,17(4):235-236.
59. Luo Wei, Wan Lanqing, Ma Chaoying. Protective effects of Shenfu injection onpulmonary injury due to endotoxin shock in rabbits. Chin Crit Care Med, 1995, 7(2):68-70.
60.彭成,雷载权.四君子汤对消化、运动、吸收作用的实验研究.中药药理与临床.1995,11(5):6-8.
61.易崇勤,孙建宁,张家俊,等.四君子汤调整小鼠运化功能紊乱的实验研究.中国中西医结合杂志,1997,17(1):42-44.
62.广州中医药学院脾胃研究组.四君子汤对动物离体小肠运动的影响.新中医,1978,5:53-55.
63.胡燕,陈德伟,王建华,等.四君子汤不同提取物及其对家兔离体小肠运动影响.新中医,1986,(6):53-53.
64.王汝俊,胡英杰,杜群,等.四君子汤对胃肠运动双向调节作用的物质基础研究.中药药理与临床,2001.17(6):3-4.
65.张曼,陈蔚文,叶富强.等.四君子汤A、B成分双向调节大鼠胃运动的M受体作用机制.河南中医药学刊,2002.17(4):9-11.
66.叶富强,陈蔚文,李茹柳.等.四君子汤提取物对大鼠胃肠活动的影响.中药药理与临床,2002.18(3):2-4.
67.黄树明,梁明,孙二堂.等.四君子汤对大鼠胃肠推进运动的影响.中医杂志.1988.(9):60-60.
68.张曼,叶富强,陈蔚文,等.四君子汤提取对番泻叶致小鼠腹泻的影响.中药药理与临床.2002-18(5):12-13.
69.任平,黄熙,谢良杰.四君子汤对脾虚模型大鼠胃动素和前列腺素E2含量的影响.中药药理与临床,1994,(6):7-8.
70.任平,黄熙,张莉,等.四君子汤对实验性脾虚大鼠胃捧空率的影响.中国中西医结合杂志.2000,20(8):596-598.
71.魏彦明,宗瑞谦,杨孝朴,等.实验性脾虚证大鼠血浆胃泌素和胃动素含量变化及四君子汤对其调整作用.中国兽医学报,2001,21(3):281-283.
72.宋开源,刘旭光,汪开明,等.辰、戌时辰四君子汤治疗对“脾虚证”大鼠血清胃泌素昼液节律性的影响.成都中医药大学学报,1996,19(1):32-35.
73.易崇勤,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响.北京中医药大学学报,1997.20(6):31-34.
74.彭成,雷载权.四君子汤抗脾虚动物胃肠细胞实验损伤的机理研究.中药药理与临床,1996,(1):1-4.
75.姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠牯膜细胞增殖动力学的影响.世界华人消化杂志,1999.7(6) 550-550.
76.刘良,周华,王培训,等.四君子汤复方总多糖对小鼠肠道黏膜相关淋巴组织的影响.中国免疫学杂志,2000,17(4):204-207.
2. Fung M, Loubser PG, Undar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg. 2001,122(1):113-122.
3. Meloni L, Abbruzzese PA, Cardu G, Aru GM, et al. Detection of microbubbles released by oxygenators during cardiopulmonary bypass by intraoperative transesophageal echocardiography. Am J Cardiol. 1990,15;66(4):511-4. No abstract available.
4. St-Pierre J, Fortier LP, Couture P, Hebert Y. Massive gastrointestinal hemorrhage after transoesophageal echocardiography probe insertion. Can J Anaesth. 1998,45(12): 1196- 1199.
5. Perugini RA, Orr RK, Porter D, Dumas EM, et al. Gastrointestinal complications following cardiac surgery. An analysis of 1477 cardiac surgery patients. Arch Surg. 1997,132(4):352-357.
6. Sinclair DG, Houldsworth PE, Keogh B, Pepper J, et al. Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intensive Care Med. 1997,23(5):510-516.
7. Klemperer JD, Ko W, Krieger KH, Connolly M, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg. 1998,65(1):85-87.
8. Mollhoff T, Loick HM, Van Aken H, et al. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Anesthesiology. 1999,90(1):72-80.
9. Hyde JA, Riddington DW, Hutton P, et al. Prevention of remote organ injury in cardiopulmonary bypass: the impact of flow generation technique. Artif Organs. 1997,21(7):825-829.
10. St-Pierre J, Fortier LP, Couture P, et al. Massive gastrointestinal hemorrhage after transoesophageal echocardiography probe insertion. Can J Anaesth. 1998 ,45(12):1196-1199.
11. McNicol L, Andersen LW, Liu G, et al. Markers of splanchnic perfusion and intestinal translocation of endotoxins during cardiopulmonary bypass: effects of dopamine and milrinone. J Cardiothorac Vasc Anesth. 1999,13(3):292-298.
12. Ogino H, Miki S, Ueda Y, Tahata T. A case of bowel necrosis due to acute mesenteric ischemia following pulsatile cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 1998 ,4(1):34-36.
13.郑利民刘小玲夏中元.体外循环心脏手术中复方丹参注射液对胃肠道保护作用的临床观察.中国中西医结合杂志,2001,21(3):177-179.
14.詹丽英,夏中元,夏芳,等.参附注射液对体外循环期间胃肠灌注及氧合的影响.中国现代医学杂志,2005,15(18):2814-2816.
1. Williams EA, W elty SE,G eske RS,et a1.Liquid lung ventilation reduces neutrophil sequestration in a neonatal swine model of cardiopulmonary bypass. Crit Care Med,2001,29(4):789-795.
2. Baldwin RT, Kadipasaoglu KA,Radovancevic B,et a1. The development of aclinically relevant canine model of postperfusion syndrome. ASAIO Trans,1991,37(3):M484-485.
3. Grehan JF,Casagrande I,Oliveira EL,et a1. A juvenile sheep model for the long-term evaluation of stentless bioprostheses implanted as aortic root replacements.J Heart Valve Dis,2001,10(4):505-512.
4. Kim WG, Moon HJ, Won TH, et al. Rabbit model of cardiopulmonary bypass. Perfusion,1999,14(2):101-105.
5.张石江,高声甫,高采璋.微型体外循环和兔体外循环.中华实验外科杂志,1991,8(1):46-47.
6.于洋,叶明,夏求明.兔体外循环模型的建立.中国胸心血管外科杂志,2003,10(2):151-152.
7.徐鹏,易定华.兔体外循环对胃泌素及其受体的影晌.第四军医大学学报,2000,21(4):302-304.
8.张斌杰,张永奎,乐涵波,等.兔体外循环氧合器改装和使用的实验研究医疗装备,2002,15(1):32-34.
9. Rogers AT. A rabbit model of the brain and cardiopulmonary bypass. Anesthesiology,1998,88(6):565-566.
10. Kuratani T, Matsuda H, Sawa Y, et al. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1992,103(6):564-568.
11. Xu X, Zhou Y, Ma Q, et al. Establishing a resuscitation model in rabbits withclosed-thoracic cardiopulmonary bypass.Resuscitation,1994,27(1):61-66.
1 Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg,1993,55(55):l080-1086.
2 Martin LF,Booth FV,Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med,1993,21(1):19-30.
3 Ohri SK,Becket J,Brannan J,et a1.Effects of cardiopulmonary bypass on gut blood flow,oxygen utilization,and intramucosal pH.Ann Thorac Surg,1994,57(5):1193-1199.
4胡小琴.血管手术时炎症反应.中华麻醉学杂志.2001,21(10):592-595.
5. Thoren A,Jakob SM,Pradl R,et a1.Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism:an observational study on postcardiac surgical patients.Crit Care Med,2CO0,28(11):3649-3654.
6. Bichel T,Kalangos A,Rouge JC. Can gastric intramucosal pH (pHi)predict outcome of paediatric cardiac surgery?.Paediatr Anaesth,1999,9(2):129-134.
7黎君友,吕艺,付小兵,等.二胺氧化酶在创伤后肠道损伤中变化及意义.中国危重病急救医学,2000,12(8):482-484.
8乐桥良,张捷,许其增,等.一氧化氮在奥美拉唑对大鼠胃粘膜保护中的作用[J].第一军医大学学报,2001,21(12):926—928.
9.陆国明,李玉梅,郭连军,等.应激状态下NO的胃粘膜保护作用及其与壁细胞泌酸的关系[J].中国应用生理学杂志,2005,21(3):301—304.
10.Arroyo MT,Lanas A,Sainz R.Prevention and healing of experimental indomethacin- induced gastric lesions:effects of ebrotidine,omeprazole and ranitidine.Eur J Gastroenterol Hepatol, 2000,12(3):313-318.
11董小超,易定华,刘金成,等.体外循环心脏手术中奥美拉唑对胃肠道保护作用的临床观察.中国急救医学,2006,26(5):331-333.
12 Olcb L.Effect of omeprazole on gastric acid secretion a plasma gastrin man[J].Scand J Gastroenterol,1989,24(Suppl 166):27—32.
13. Ogino H, Miki S, Ueda Y,et a1. A case of bowel necrosis due to acute mesenteric ischemia following pulsatile cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 1998,4(1):34-36.
14.彭成,雷载权.四君子汤对消化、运动、吸收作用的实验研究.中药药理与临床,1995,11(5):6-8.
15易崇勤,孙建宁,张家俊,等.四君子汤调整小鼠运化功能紊乱的实验研究.中国中西医结合杂志,1997,17(1):42-44.
16张曼,陈蔚文,叶富强.等.四君子汤A、B成分双向调节大鼠胃运动的M受体作用机制.河南中医药学刊,2002,17(4):9-11.
17任平,黄熙,谢良杰.四君子汤对脾虚模型大鼠胃动素和前列腺素E2含量的影响.中药药理与临床,1994,10(6):7-8.
18任平,黄熙,张莉,等.四君子汤对实验性脾虚大鼠胃捧空率的影响.中国中西医结合杂志,2000,20(8):596-598.
19魏彦明,宗瑞谦,杨孝朴,等.实验性脾虚证大鼠血浆胃泌素和胃动素含量化及四君子汤对其调整作用.中国兽医学报,2001,21(3):281-283.
20.宋开源,刘旭光,汪开明,等.辰、戌时辰四君子汤治疗对“脾虚证”大鼠血清胃泌素昼液节律性的影响.成都中医药大学学报,1996,19(1):32-35.
21易崇勤,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响.北京中医药大学学报,1997,20(6):31-34.
22彭成,雷载权.四君子汤抗脾虚动物胃肠细胞实验损伤的机理研究.中药药理与临床,1996,12(1):1-4.
23刘良,周华,王培训,等.四君子汤复方总多糖对小鼠肠道黏膜相关淋巴组织的影响.中国免疫学杂志,2000,17(4):204-207.
1. Tsiotos GG,Mulany CJ,Zietlow S,et a1. Abdominal complications following cardiac surgery. Am J Surg,1994,167:553—557.
2. Mercado PD,Farid H,O Connell TX,et a1.Gastrointestinal complications associated with cardiopulmonary bypass procedures. Am J Surg,1994,60:789—792.
3. Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut p ermeability. Ann Thorac Surg,1993,55:l080-1086.
4. Martin LF,Booth MV,Kar]stadt RG.et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med,1993,21:19—30.
5. Sunil K,Jenny B,John B,et a1.Effects of cardiopulmonary bypass on gut blood flow,oxygen utilization,and intramucosal pH[J].Ann Throae Surg,1994,57:1193-1199.
6. Thoren A,Jakob SM,Pradl R,et a1.Jejunal and gastric mucosal perfusion versus splanehnie blood flow and metabolism:an observational study on postcardiac surgical patients[J].Crit Care Med,2CO0,28:3649-3654.
7. Biehel T,Kalangos A,Rouge JC. Can gastric intramucosal pH predict outcome of paediatric cardiac surgery?[j].Paediatr Anaesth,1999,9:129.
8. Arroyo MT,Lanas A,Sainz R,et a1.Prevention and healing of experimental indomethac in induced gastric lesions : effects of ebrotidine , omeprazole and ranitidine[J].Eur J Gastroenterol Hepatol, 2000,12(3):313—318.
9. Arroyo MT,Lanas A,Sainz R,et a1.Prevention and healing of expefimental indomethac in induced gastric lesions:effects of ebrotidine,omeprazole and ranitidine. Eur J Gastroenteml Hepatol,2000,12(3):313-318.
10. Anna-Leena K,Ruuska T,Karikoski,et a1.A randomized controlled study of prophylactic ranitidine in preventing stress-induced gastricmucosal lesions in neonatal intensive coi'e unit patients. Cfit Care Med,1997,25(2):346-351.
11. Tenenbaum J.The epidemiology of nonsteroidal anti- inflammatory drugs. Can J Gastroenteml,1999,13(2):l19-122.
12.许得盛,沈自尹,王文健,等.右归饮、四君子汤、桃红四物汤调节肾虚、脾虚、血瘀证患者免疫功能的观察.中国中西医结合杂志,1999,19:712-714.
1. Oudemans-van Straaten HM, Jansen PG, Hoek FJ, et al. Intestinal permeability, circulating, endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 1996; 10(2):187-194.
2. Sinclair DG, Haslam PL, Quinlan GJ, et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest, 1995, 108,718-724
3. Perugini RA, Orr RK, Porter D, et al. Gastrointestinal complications following cardiac surgery. An analysis of 1477 cardiac surgery patients. Arch Surg, 1997, 132(4):352-357.
4. Plestis KA, Gold JP. Importance of blood pressure regulation in maintaining adequate tissue perfusion during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg, 2001, 13(2):170-175.
5. Holmes JH, Lieberman JM, Probert CB, et a1. Elevated intestinal fatty acid binding protein and gastrointestinal complication following cardiopulmonary bypass: a preliminary analysis. J Surg Res, 2001, 100(9): 192-196.
6. Ohri SK, Bowels CW, Mathle RT, et a1. Efect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow . Ann Thorac Surg,1997, 64(10): 163-169.
7. Thoren A, Jakob SM, Pradl R, et a1. Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism: an observational study on postcardiac surgical patients. Crit Care Med, 2000, 28(5):3649-3654.
8. Slater JM, Orszulak TA, Cook DJ. Distribution and hierarchy of regional blood flowduring hypothermic cardiopulmonary bypass. Ann Thorac Surg, 2001, 72(2): 542-54.
9. Fung M, Loubser PG, Undar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg., 2001, 122(1):113-22.
10. Meloni L, Abbruzzese PA, Cardu G, Aru GM, et al. Detection of microbubbles released by oxygenators during cardiopulmonary bypass by intraoperative transesophageal echocardiography. Am J Cardiol, 1990, 66(4): 511-514.
11. Blauth CI, Arnold JV, Schulenberg WE, et al. Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. J Thorac Cardiovasc Surg. 1988, 95(4):668-76.
12. El Eter E, Hagar HH, AI-Tuwaijiri A, et a1. Nuclear factor-kappaB inhibition by pyrrolidinedithio carbamate attenuates gastric ischemia-reperfusion injury in rats. Can J Physiol Pharmacol, 2005, 83 (6): 483-492.
13. Kim H, Hwan Kim K. Role of nitric oxide and mucus in ischemia-reperfusion induced gastric mucosal injury in rats. Pharmacology, 2001, 62(4):200-207.
14. Wada K, Kamisaki Y, Ohkura T, et a1. Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats. Am J Physiol, 1998, 274(3 Pt 1):G465-471.
15. Derin N, zgut-Uysal VN, Agac A, et a1. L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. Physiol Pharmacol, 2004, 5(3):595-606.
16.叶方,徐鑫荣.创伤性休克大鼠心肺血栓调节蛋白表达的变化和意义.安徽医药,2005,9(8):606-608.
17. Wada K, Kamisaki Y, Kitano M et a1. A new gastric ulcer model induced by schemia-reperfusion in the rat; role of leukoeytes on ulceration in rat stomach. Life Sci, 1996, 59(19):295-301.
18. Brzozowski T, Konturek PC, Konturek SJ, et a1. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol, 2005, 56(Suppl5): 33-55.
19. Kotani T, Kobata A , Nakamura E , et a1 . Roles of cyclooxygenase-2 and Prostacyclin/IP receptors in mucosal defense against Isehemia/Reperfusion injury in mouse stomach.J Pharmacol Exp Ther,2006,316(2):547-555
20. Villegas I,Martin AR,Toma W,et a1.Rosiglitazone,an agonist of peroxisome proliferators-activated receptor gamma,protects against gastric ischemia-reperfusion damage in rats:role of oxygen free radicals generation.Eur J Pharmacol,2004,505(1-3):195-203.
21. Wada K,Nakajima A,Takahashi H,et a1.Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion.Am J Physiol Gastrointest Liver[J].Physiol,2004,287(2):G452-458.
22. Muia C, Mazzon E, Crisafulli C. Role of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice. Shock, 2006, 25(1):17-22.
23. Byhahn C, Strouhal U, Martens S, et al. Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg, 2001, 25(9):1140-1144.
24.徐鹏,易定华.兔体外循环对胃泌素及其受体的影响.第四军医大学学报,2000,21(4):502-504.
25.黑飞龙,龙村,孙桂民,等.体外循环心内直视手术中胃肠激素变化.中华实验外科杂志,2003,20(4):375.
26. Withington DE,Man WK,Elliott MJ . Histamine release during paediatric cardiopulmonary bypass. Can J Anaesth. 1993, 40(4):334-339.
27. Giuseppe D, Ancona, MD,Richard Baillot, MD,Brigitte Poirier, MD,et al. Determinants of Gastrointestinal Complications in Cardiac Surgery. Tex Heart Inst J 2003; 30(4):280-285.
28. Tsiotos GG, Mullany CJ, Zietlow S, et al. Abdominal complications following cardiac surgery. Am J Surg, 1994; 167(6):553-557.
29. Huddy SP, Joyce WP, Pepper JR. Gastrointestinal complications in 4473 patients who underwent cardiopulmonary bypass surgery. Br J Surg, 1991, 78(3):293-296.
30. Zacharias A, Schwann TA, Parenteau GL, et a1.Predictors of gastrointestinal complicationsin cardiac surgery. Tex Heart Inst J, 2000, 27(2):93-99.
31. Edmunds L H Jr. Complications of cardiac surgery. Cardiac Surgery in the Adult. New York: Mcgraw-Hil, 1997, 389-392.
32. Mierdl S,Meininger D,Dogan S.Abdominal complications after cardiac surgery.Ann Acad Med Singapore,2001,30(3):245-249.
33. Christenson JT, Schmuziger M, Maurice J. et al. Postoperative visceral hypotension the common cause for gastrointestinal complications after cardiac surgery. Thorac Cardiovas Surg, 1994, 42(3):152-157.
34.郭惠明,张镜芳,吴若彬,等.心脏手术后腹部并发症.中山大学学报(医学科学版),2004,25(3S):271-273.
35. Huwer H,Winning J,Stranb U,et al.Clinically diagnosed nonocclusive mesenteric ischemia after cardiopulmonary bypass:retrospective study. Vascular, 2004, 12(2):114-120.
36. 36 Akpinar B, Sagbae E,Gudeo M.Acute gastrointestinal complications after open heart surgery.Asian CardiovascThorac Ann,2000,8:109-113..
37. Garofalo M,Borioni R,Nardi P,et a1.Early diagnosis of acute mesenteric ischemia after cardiopulmonary bypass.J Cardiovasc Surg(Torino),2002, 43(4):455-459.
38. Wan S,Arifi AA,Chan CS.Is hyperamylasemia after cardiac surgery due to cardiopulmonary bypass? Asian Cardiovasc Thorac Ann,2002,10(2):115-118.
39.董国华,景华,李德闽,等.体外循环术后消化系统功能障碍的临床分析.中国医师杂志,2004,(6)11:1498-1500.
40. Ghosh S,Roberts N,Firmin RK,et a1.Risk factors for intestinal ischaemia cardiac surgical patients.Eur J Cardiothorac Surg, 2002,21(3):411-416.
41. Spotnitz WD, Sanders RP, Hanks JB, et al. General surgical complications can be predicted after cardiopulmonary bypass. Ann Surg, 1995; 221:489-97.
42.史昕云,夏正远,万建国,等.复方丹参注射液对心内直视手术心肌缺血再灌注后血清内皮素及前列环素/血栓素A2比值的影响.中国中西医结合杂志,2000,20(12):896-898.
43.常青,李和泉,原泽茂.丹参对大鼠胃泌素所致胃液分泌、胃体、十二指肠粘膜血流和胃窦运动的影响.中国病理生理杂志,1994,10(3):306-309.
44.常江,邓长生,沈佩弟,等.丹参对大鼠乙醇性胃粘膜损伤的保护作用的研究.中国病理生理杂志,994;10(1):27-29.
45.郑利民刘小玲夏中元.体外循环心脏手术中复方丹参注射液对胃肠道保护作用的临床观察.中国中西医结合杂志,2001,21(3):177-179.
46.田宝文,张强华,周钢,等.丹参和654—2对体外循环胃肠缺血再灌注损伤的保护作用.中国体外循环杂志,2004,2(3):142-144.
47.田宝文,张强华,周钢.丹参注射液对体外循环心脏手术后胃肠功能的影响.心血管康复医学杂志,2004,13(4):396-397.
48.顾家珍,夏正远,杨光,等.复方丹参对体外循环下心肌缺血再灌注后脂质过氧化反应的影响.中华实验外科杂志,1996:13(5):282-283.
49.吴志,夏正远,黄海波,等.复方丹参对心内直视手术心肌缺血再灌注后血清过氧化脂质及前列环素变化的影响.临床麻醉学杂志,2002,18(5):242-244.
50.阎勇,田伏洲,尹致志,等.丹参对肠道屏障的保护作用机制研究.中华消化杂志.2000,20(6):4O9-411.
51.龙村,邓硕曾.体外循环对消化系统的影响.国外医学麻醉学与复苏分册.1998;19(3):170-172
52.刘先义,邹捍东,余金甫,等.参附注射液对缺血再灌注家兔多脏器损伤的治疗作用.中华麻醉学杂志,1997,17(7):430-432.
53.詹丽英,夏中元,夏芳,等.参附注射液对体外循环期间胃肠灌注及氧合的影响.中国现代医学杂志,2005,15(18):2814-2816.
54. XIA Zhong-yuan,ZHAN Li-ying, XIA Fang,et al.The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardiopulmonary bypass in patients undergoing cardiac surgery. Chin J Traumatol(English Edition),2003,6 (4):245-248.
55.王正荣,杨芳炬,徐彬,等.参附注射液对肠系膜微循环的作用.中药药理与临床,2000;17(4):8-9.
56.蓝庆荣,吴树勋,李兰芳,等.参附注射液对失血性休克家免血乳酸和PCA的影响.中成药研究,1993,5(4):13.
57.夏中元,王龙,陈雪君,等.参附注射液对休克复苏时肠黏膜保护作用机制的实验研究.中国急救医学,2001, 21 (8):447-448.
58.夏中元,郑利民.参附注射液防护肠黏膜缺血再灌注损伤的实验研究.中国创伤杂志,2001,17(4):235-236.
59. Luo Wei, Wan Lanqing, Ma Chaoying. Protective effects of Shenfu injection onpulmonary injury due to endotoxin shock in rabbits. Chin Crit Care Med, 1995, 7(2):68-70.
60.彭成,雷载权.四君子汤对消化、运动、吸收作用的实验研究.中药药理与临床.1995,11(5):6-8.
61.易崇勤,孙建宁,张家俊,等.四君子汤调整小鼠运化功能紊乱的实验研究.中国中西医结合杂志,1997,17(1):42-44.
62.广州中医药学院脾胃研究组.四君子汤对动物离体小肠运动的影响.新中医,1978,5:53-55.
63.胡燕,陈德伟,王建华,等.四君子汤不同提取物及其对家兔离体小肠运动影响.新中医,1986,(6):53-53.
64.王汝俊,胡英杰,杜群,等.四君子汤对胃肠运动双向调节作用的物质基础研究.中药药理与临床,2001.17(6):3-4.
65.张曼,陈蔚文,叶富强.等.四君子汤A、B成分双向调节大鼠胃运动的M受体作用机制.河南中医药学刊,2002.17(4):9-11.
66.叶富强,陈蔚文,李茹柳.等.四君子汤提取物对大鼠胃肠活动的影响.中药药理与临床,2002.18(3):2-4.
67.黄树明,梁明,孙二堂.等.四君子汤对大鼠胃肠推进运动的影响.中医杂志.1988.(9):60-60.
68.张曼,叶富强,陈蔚文,等.四君子汤提取对番泻叶致小鼠腹泻的影响.中药药理与临床.2002-18(5):12-13.
69.任平,黄熙,谢良杰.四君子汤对脾虚模型大鼠胃动素和前列腺素E2含量的影响.中药药理与临床,1994,(6):7-8.
70.任平,黄熙,张莉,等.四君子汤对实验性脾虚大鼠胃捧空率的影响.中国中西医结合杂志.2000,20(8):596-598.
71.魏彦明,宗瑞谦,杨孝朴,等.实验性脾虚证大鼠血浆胃泌素和胃动素含量变化及四君子汤对其调整作用.中国兽医学报,2001,21(3):281-283.
72.宋开源,刘旭光,汪开明,等.辰、戌时辰四君子汤治疗对“脾虚证”大鼠血清胃泌素昼液节律性的影响.成都中医药大学学报,1996,19(1):32-35.
73.易崇勤,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响.北京中医药大学学报,1997.20(6):31-34.
74.彭成,雷载权.四君子汤抗脾虚动物胃肠细胞实验损伤的机理研究.中药药理与临床,1996,(1):1-4.
75.姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠牯膜细胞增殖动力学的影响.世界华人消化杂志,1999.7(6) 550-550.
76.刘良,周华,王培训,等.四君子汤复方总多糖对小鼠肠道黏膜相关淋巴组织的影响.中国免疫学杂志,2000,17(4):204-207.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |